Delivery Order SPE2DR25D3103-SPE2DR26F9Y36
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $21,516.67 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on January 15, 2026, with completion scheduled for February 6, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a $40,764.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on November 3, 2025, with an ultimate completion date of November 25, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where the contractor maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $48.7 million delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was made on December 2, 2025, with an ultimate completion date of December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $18,566.92 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the company's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,589.70 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Mekinist 0.5 mg tablets and has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a $19.3K delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of May 12, 2025, and performance based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $9,670.51. The award, issued on May 8, 2025, with an ultimate completion date of May 30, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y36Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,390.46 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) with a completion date of February 9, 2026. The contract was awarded on January 16, 2026, using firm fixed-price pricing with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling Cencora and its subsidiary to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, as a critical vendor in the federal medical procurement supply chain, routinely fulfills such delivery orders for prescription medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 1/15/26 |